KemOn Signs Toxicity Testing Research Contract Worth 2 Billion KRW

[Asia Economy Reporter Park Jihwan] KemOn announced on the 5th that it has signed a research contract for toxicity testing using rodents for combination drugs worth 2.075 billion KRW.


This corresponds to 10.7% of recent sales revenue.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.